Congress Wealth Management LLC DE Increases Holdings in Balchem Co. (NASDAQ:BCPC)

Congress Wealth Management LLC DE grew its holdings in Balchem Co. (NASDAQ:BCPC) by 5.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 50,711 shares of the basic materials company’s stock after buying an additional 2,393 shares during the quarter. Congress Wealth Management LLC DE owned approximately 0.16% of Balchem worth $8,266,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Westside Investment Management Inc. bought a new position in Balchem in the third quarter worth about $27,000. R Squared Ltd purchased a new position in shares of Balchem during the 4th quarter worth approximately $29,000. Wilmington Savings Fund Society FSB bought a new position in shares of Balchem in the 3rd quarter worth approximately $35,000. Venturi Wealth Management LLC purchased a new position in shares of Balchem in the 4th quarter valued at approximately $95,000. Finally, Smartleaf Asset Management LLC boosted its position in shares of Balchem by 230.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company’s stock valued at $106,000 after purchasing an additional 450 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors.

Balchem Stock Down 0.7 %

Shares of NASDAQ:BCPC opened at $163.33 on Wednesday. Balchem Co. has a 12-month low of $137.69 and a 12-month high of $186.03. The stock has a market capitalization of $5.31 billion, a price-to-earnings ratio of 41.56, a PEG ratio of 4.41 and a beta of 0.63. The stock has a fifty day simple moving average of $164.97 and a two-hundred day simple moving average of $169.31. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19.

Balchem (NASDAQ:BCPC) last posted its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.11 by ($0.08). The company had revenue of $240.00 million for the quarter, compared to the consensus estimate of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. On average, research analysts anticipate that Balchem Co. will post 4.64 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on BCPC. HC Wainwright reissued a “buy” rating and set a $190.00 price objective on shares of Balchem in a research report on Monday, February 24th. StockNews.com cut shares of Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Finally, Sidoti upgraded shares of Balchem to a “hold” rating in a report on Tuesday, February 25th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.